CDMO News
BioVersys and GSK Expand Collaboration to Accelerate TB Treatment
BioVersys AG, a clinical stage biopharmaceutical company, has expanded its strategic collaboration with GSK plc to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB). The small molecule, developed in a public-private collaboration with GSK, Pasteur
9 May 2024
Stay ahead of trends and best practices
